Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,798,018
-
Total 13F shares
-
43,465,728
-
Share change
-
+367,096
-
Total reported value
-
$9,100,764,342
-
Put/Call ratio
-
48%
-
Price per share
-
$209.38
-
Number of holders
-
436
-
Value change
-
+$90,799,372
-
Number of buys
-
209
-
Number of sells
-
210
Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q3 2022
As of 30 Sep 2022 UNITED THERAPEUTICS Corp - Common Stock (UTHR) had 436 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 43,465,728 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., FMR LLC, Avoro Capital Advisors LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, Avidity Partners Management LP, JANUS HENDERSON GROUP PLC, and Palo Alto Investors LP.
This table shows 443 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.